Macro 108 (aka Joe Kim) and Steve Palley discuss inflation. Breakdown drivers/inhibitors and talk about investment implications. 
LINKS:
<ul>
 <li><a href="https://www.linkedin.com/pulse/money-credit-debt-ray-dalio/" rel="ugc noopener noreferrer" target="_blank">Ray Dalio on The Long Term Debt Cycle</a></li>
</ul>

Macro 108 (aka Joe Kim) and Steve Palley discuss inflation. Breakdown drivers/inhibitors and talk about investment implications. LINKS: Ray Dalio on The Long Term Debt Cycle

Macro 108 (aka Joe Kim) and Steve Palley discuss inflation. Breakdown drivers/inhibitors and talk about investment implications.&nbsp;
LINKS:
<ul>
 <li><a href="https://www.linkedin.com/pulse/money-credit-debt-ray-dalio/" rel="noopener noreferrer">Ray Dalio on The Long Term Debt Cycle</a></li>
</ul>

#5. Inflation: Drivers/Inhibitors and Investment Implications

Two dads teaming up to build wealth for their families and to make sense of the complex and ever changing financial markets. 

We discuss:
- Philosophies on investing
- Specific investment ideas
- Key macro trends impacting an investment thesis

Note: We are not investment professionals and are discussing our own investment choices for the purpose of entertainment.

We are:
- Joe Kim, @jokim1: https://www.linkedin.com/in/jokim/
- Steve Palley, @spall03: https://www.linkedin.com/in/spall/

Business

Investing

Two dads teaming up to build wealth for their families and to make sense of the complex and ever changing financial markets. We discuss: - Philosophies on investing - Specific investment ideas - Key macro trends impacting an investment thesis Note: We are not investment professionals and are discussing our own investment choices for the purpose of entertainment. We are: - Joe Kim, @jokim1: https://www.linkedin.com/in/jokim/ - Steve Palley, @spall03: https://www.linkedin.com/in/spall/

Share #5. Inflation: Drivers/Inhibitors and Investment Implications

Sign up to save your podcasts

#5. Inflation: Drivers/Inhibitors and Investment Implications

#5. Inflation: Drivers/Inhibitors and Investment Implications